Literature DB >> 2642741

Induction of tumorigenicity and lack of in vitro growth requirement for 12-O-tetradecanoylphorbol-13-acetate by transfection of murine melanocytes with v-Ha-ras.

R E Wilson1, T P Dooley, I R Hart.   

Abstract

A nontumorigenic line of murine melanocytes, Mel-ab, has been transfected with the v-Ha-ras gene under transcriptional control of the Moloney murine leukemia virus long terminal repeat. Transfectants produced rapidly growing undifferentiated melanomas in recipient mice. The inhibition of melanin production in transformed cells, observable both in vitro and in vivo, suggests that ras may affect melanocyte cytodifferentiation. Mel-ab cells require the continual presence of 12-O-tetradecanoylphorbol-13-acetate, or other activators of protein kinase C, for in vitro growth. Transfectants expressing v-Ha-ras no longer manifested this requirement and were actually growth inhibited by the addition of protein kinase C activators. These results are consistent with the notion that ras acts via the protein kinase C pathway in conferring autonomous growth on Mel-ab cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642741

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Comparison of Xiphophorus and human melanoma transcriptomes reveals conserved pathway interactions.

Authors:  Yuan Lu; Mikki Boswell; William Boswell; Susanne Kneitz; Michael Hausmann; Barbara Klotz; Janine Regneri; Markita Savage; Angel Amores; John Postlethwait; Wesley Warren; Manfred Schartl; Ronald Walter
Journal:  Pigment Cell Melanoma Res       Date:  2018-01-29       Impact factor: 4.693

2.  CDF-1-mediated repression of cell cycle genes targets a specific subset of transactivators.

Authors:  J Zwicker; F C Lucibello; V Jérôme; S Brüsselbach; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

3.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo.

Authors:  L Chin; J Pomerantz; D Polsky; M Jacobson; C Cohen; C Cordon-Cardo; J W Horner; R A DePinho
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

4.  Malignant melanoma in transgenic mice.

Authors:  M Bradl; A Klein-Szanto; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

5.  Active Notch1 confers a transformed phenotype to primary human melanocytes.

Authors:  Chelsea C Pinnix; John T Lee; Zhao-Jun Liu; Ronan McDaid; Klara Balint; Levi J Beverly; Patricia A Brafford; Min Xiao; Benjamin Himes; Susan E Zabierowski; Yumi Yashiro-Ohtani; Katherine L Nathanson; Ana Bengston; Pamela M Pollock; Ashani T Weeraratna; Brian J Nickoloff; Warren S Pear; Anthony J Capobianco; Meenhard Herlyn
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

6.  Phenotypic reversions at the W/Kit locus mediated by mitotic recombination in mice.

Authors:  P De Sepulveda; J L Guenet; J J Panthier
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

7.  Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and E1a oncogenes.

Authors:  S Ramon y Cajal; S Suster; R Halaban; E Filvaroff; G P Dotto
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

8.  Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.

Authors:  G P Dotto; G Moellmann; S Ghosh; M Edwards; R Halaban
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

Review 9.  Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.

Authors:  Florian Rambow; Jean-Christophe Marine; Colin R Goding
Journal:  Genes Dev       Date:  2019-10-01       Impact factor: 11.361

10.  Ric-8A gene deletion or phorbol ester suppresses tumorigenesis in a mouse model of GNAQ(Q209L)-driven melanoma.

Authors:  B R Patel; G G Tall
Journal:  Oncogenesis       Date:  2016-06-27       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.